Vajram-And-RaviVajram-And-Ravi
hamburger-icon

World Schizophrenia Awareness Day, 2023

28-09-2024

06:30 PM

timer
1 min read
World Schizophrenia Awareness Day, 2023 Blog Image

Overview:

The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s new oral medicine, Cobenfy, for the treatment of schizophrenia in adults.

About Schizophrenia:

  • It is a chronic, severe mental disorder that affects the way a person thinks, acts, expresses emotions, perceives reality, and relates to others.
  • It mostly affects young adults in the productive age group.
  • One in every 100 people experiences schizophrenia and men are twice as likely to develop this condition as compared to women.
  • Symptoms of Schizophrenia:
    • It can differ from person to person, but they generally fall into three main categories: psychotic, negative, and cognitive.
    • Psychotic symptoms include Hallucinations, Delusions, thought disorder, Movement disorder.
    • Negative symptoms include loss of motivation, loss of interest or enjoyment in daily activities, withdrawal from social life, difficulty showing emotions, and difficulty functioning normally.
    • Cognitive symptoms include problems in attention, concentration, and memory.
  • Treatment:
    • Though there is no cure for schizophrenia, a variety of antipsychotic medications are effective in reducing the psychotic symptoms present in the acute phase of the illness.
    • Psychological treatments such as cognitive behavioral therapy or supportive psychotherapy may reduce symptoms and enhance function.

Q1: What is Alzheimer's?

It is a brain condition that causes a progressive decline in memory, thinking, learning, and organizing skills. It is the most common type of dementia, accounting for 60-80% of all dementia cases. It involves parts of the brain that control thought, memory, and language.

Source: New drug for schizophrenia has experts excited